Amlodipine Besylate Tablet
Product Images NDC 71335-0833

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71335-0833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

This is a summary of a study with 1318 patients, categorized by age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI status. The study compares the use of Amlodipine versus a placebo in treating patients with at least one vessel with over 60% stenosis. The hazard ratio and confidence interval are also provided. The mean sitting baseline systolic blood pressure is reported to be 129 mmHg.*

FDA Label Image

Structure (Ima)

FDA Label Image

Label Image (Lbl713350833)

This is a medication description for a Amlodipine Besylate 2.5mg Tablet. It is manufactured by InvaGen Pharmaceuticals Inc. The tablet is white, round, and marked with 237 and 16. It should be stored at a room temperature of 20°-25°C (68°-77°F). The medication should be kept out of reach of children. The tablet comes in a bottle of 30 tablets and the expiration date is not available. The National Drug Code (NDC) is 7133508331 03678301523487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.